TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Vaccines
Researchers describe findings in Tuberculosis Vaccines studies
January 17th, 2006
Tuberculosis Vaccines research advances have been reported from the United States, France and United Kingdom. Study 1: Boosting with the Mycobacterium tuberculosis major secretory protein enhances the protective efficacy of M. bovis BCG vaccination against tuberculosis. According to a study from the United States, "Tuberculosis continues to ravage humanity, killing two million people yearly. Most cases occur in areas of the world to which the disease is endemic, where almost everyone is vaccinated early in life with M. bovis BCG, the currently available vaccine against tuberculosis. Thus, while more potent vaccines are needed to...
Source: TB & Outbreaks Week (2006-01-17)
|
